Literature DB >> 10673504

Absence of Wee1 ensures the meiotic cell cycle in Xenopus oocytes.

N Nakajo1, S Yoshitome, J Iwashita, M Iida, K Uto, S Ueno, K Okamoto, N Sagata.   

Abstract

Meiotic cells undergo two successive divisions without an intervening S phase. However, the mechanism of S-phase omission between the two meiotic divisions is largely unknown. Here we show that Wee1, a universal mitotic inhibitor, is absent in immature (but not mature) Xenopus oocytes, being down-regulated specifically during oogenesis; this down-regulation is most likely due to a translational repression. Even the modest ectopic expression of Wee1 in immature (meiosis I) oocytes can induce interphase nucleus reformation and DNA replication just after meiosis I. Thus, the presence of Wee1 during meiosis I converts the meiotic cell cycle into a mitotic-like cell cycle having S phase. In contrast, Myt1, a Wee1-related kinase, is present and directly involved in G(2) arrest of immature oocytes, but its ectopic expression has little effect on the meiotic cell cycle. These results strongly indicate that the absence of Wee1 in meiosis I ensures the meiotic cell cycle in Xenopus oocytes. Based on these results and the data published previously in other organisms, we suggest that absence of Wee1 may be a well-conserved mechanism for omitting interphase or S phase between the two meiotic divisions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673504      PMCID: PMC316360     

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  56 in total

1.  Cytoplasmic polyadenylation elements mediate masking and unmasking of cyclin B1 mRNA.

Authors:  C H de Moor; J D Richter
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 2.  The cdc25 M-phase inducer: an unconventional protein phosphatase.

Authors:  J B Millar; P Russell
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

Review 3.  Checkpoint pathways come of age.

Authors:  P Nurse
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

4.  Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.

Authors:  J N Dumont
Journal:  J Morphol       Date:  1972-02       Impact factor: 1.804

5.  Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15.

Authors:  P R Mueller; T R Coleman; A Kumagai; W G Dunphy
Journal:  Science       Date:  1995-10-06       Impact factor: 47.728

6.  Mos-induced p42 mitogen-activated protein kinase activation stabilizes M-phase in Xenopus egg extracts after cyclin destruction.

Authors:  A S Chau; E K Shibuya
Journal:  Biol Cell       Date:  1998-11       Impact factor: 4.458

7.  On the coupling between DNA replication and mitosis.

Authors:  J Newport; M Dasso
Journal:  J Cell Sci Suppl       Date:  1989

8.  A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.

Authors:  A Palmer; A C Gavin; A R Nebreda
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 9.  Checkpoints on the road to mitosis.

Authors:  P Russell
Journal:  Trends Biochem Sci       Date:  1998-10       Impact factor: 13.807

10.  Regulation of the acquisition of meiotic competence in the mouse: changes in the subcellular localization of cdc2, cyclin B1, cdc25C and wee1, and in the concentration of these proteins and their transcripts.

Authors:  J Mitra; R M Schultz
Journal:  J Cell Sci       Date:  1996-09       Impact factor: 5.285

View more
  44 in total

1.  Essential role of MCM proteins in premeiotic DNA replication.

Authors:  Karola Lindner; Juraj Gregán; Stuart Montgomery; Stephen E Kearsey
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

2.  A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.

Authors:  Amanda Charlesworth; John A Ridge; Leslie A King; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

3.  Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1.

Authors:  Marion Peter; Christian Le Peuch; Jean-Claude Labbé; April N Meyer; Daniel J Donoghue; Marcel Dorée
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

4.  Residual Cdc2 activity remaining at meiosis I exit is essential for meiotic M-M transition in Xenopus oocyte extracts.

Authors:  M Iwabuchi; K Ohsumi; T M Yamamoto; W Sawada; T Kishimoto
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Dissolution of the maskin-eIF4E complex by cytoplasmic polyadenylation and poly(A)-binding protein controls cyclin B1 mRNA translation and oocyte maturation.

Authors:  Quiping Cao; Joel D Richter
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

6.  Geminin stabilizes Cdt1 during meiosis in Xenopus oocytes.

Authors:  Yadushyla Narasimhachar; Martine Coué
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

7.  Enforcing temporal control of maternal mRNA translation during oocyte cell-cycle progression.

Authors:  Karthik Arumugam; Yiying Wang; Linda L Hardy; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2009-12-03       Impact factor: 11.598

8.  "Ready, set, go": checkpoint regulation by Cdk1 inhibitory phosphorylation.

Authors:  J O Ayeni; S D Campbell
Journal:  Fly (Austin)       Date:  2014       Impact factor: 2.160

Review 9.  Meiosis: an overview of key differences from mitosis.

Authors:  Hiroyuki Ohkura
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-20       Impact factor: 10.005

10.  Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C.

Authors:  Eusebio Perdiguero; Marie-Jeanne Pillaire; Jean-Francois Bodart; Florian Hennersdorf; Morten Frödin; Nicholas S Duesbery; Gema Alonso; Angel R Nebreda
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.